期刊文献+

碱性调节剂对硝苯地平固体分散体体外溶出度的影响 被引量:1

Effect on the Dissolution Rate of the Solid Dispersion of Nifedipine by the Alkalizer
下载PDF
导出
摘要 目的:采用溶剂-冷冻干燥法制备硝苯地平(nifedipine,NF)速释固体分散体(SD)来提高其体外溶出度,并通过添加碱性调节剂来调节溶出微环境的pH值,进一步提高SD中药物的溶出速率。方法:以原料药在各辅料水溶液的溶解度及固体分散体的体外溶出度为指标,从聚乙烯吡咯烷酮K30(PVPK30)、羟丙甲基纤维素(HPMC)、泊洛沙姆407(Poloxamer 407)中筛选最优载体及其比例,并添加适量的碳酸钠(Na_2CO_3)来进一步调节溶出速率。结果:当以PVPK30为载体,Na_2CO_3为碱性调节剂,且NF:PVPK30:Na_2CO_3=30mg:150mg:9mg时,制备的SD中药物的溶出速率显著提高,在2h内累积溶出度百分率可达84%。 OBJECTIVE: Prepare the solid dispersions( SD) of nifedipine( NF) by the solvent-freeze drying method to improve the dissolution rate of the drug. The dissolution rate has been further improved by the alkalizer to modifier the PH.METHODS: The solid dispersions of NF have been prepared with polyvinyl pyrrolidone( PVPk30),hydroxypropyl methyl cellulose( HPMC),poloxamer407 and sodium carbonate( Na_2CO_3),respectively. The optimal carrier were chose from the solubility and dissolution test, then the dissolution rate of the drug has been further improved by the Na_2CO_3.CONCLUSION: The dissolution rate improved to the 84% during 2hours,when used PVPk30 as the carrier,Na_2CO_3 as the alkalizer and the ratio of NF: PVPk30: Na_2CO_3 was 30mg: 150mg: 9mg in this solid dispersion system.
出处 《山东化工》 CAS 2015年第22期109-111,共3页 Shandong Chemical Industry
关键词 碱性调节剂 硝苯地平 固体分散体 体外溶出度 alkalizer nifedipine solid dispersion in vitro dissolution
  • 相关文献

参考文献7

二级参考文献24

  • 1赵卫,杭太俊,刘洁,宋敏,沈建平,张银娣,张正行.吲达帕胺胶囊人体药动学和生物等效性研究[J].中国新药杂志,2005,14(11):1332-1335. 被引量:9
  • 2王展,韩立炜,任天池.葛根素-聚乙二醇6000固体分散体的制备及其溶解性能的研究[J].北京中医药大学学报,2007,30(5):346-349. 被引量:17
  • 3侯永利,杨建彬.卡维地洛固体分散体的初步研制[J].中国药房,2007,18(16):1239-1241. 被引量:2
  • 4Yuji N,Makoto S,Hikori M,et al. Azelnidipine,a new calcium channel blocker,inhibits endothdial inflammatory response by reducing intracd- lular levels of reactive oxygen species [J]. European Journal of Pharma- cology, 2006,546 : 11.
  • 5DAVID R, GUAY P. Ceofdinir : and advanced-generation, bro- adspeclrumoral eephalosporin [ J ]. Clin Ther, 2002,24 ( 4 ) : 473 -489.
  • 6PERRY C M,SCOTr L J. Cefdinir:a review of its use in the management of mild-to-moderate bacterial infections [ J ]. Drugs, 2004,64 ( 13 ) : 1433-1464.
  • 7ALEEM O, KUCHEKAR B, PORE Y,et al. Effect of β-cyclo- dextrin and hydroxypropyl β-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir [J]. J Pharm Biomed Ana,2008,47(3):535-540.
  • 8KARAVAS E, GEORGARAKIS E, SIGALAS M P, et al. In- vestigation of the release mechanism of a sparingly water- soluble drug from solid dispersions in hydrophilic carriers based on physical state of drug, particle size distribution and drug-polymer interactions [ J~. Eur J Pharm Biopharm,2007, 66 ( 3 ) :334-347.
  • 9LIU H, WANG P, ZHANG X, et al. Effects of extrusion pro-cess parameters on the dissolution behavior of indomethacin in Eudragit E PO solid dispersions [ J ]. Int J Pharm, 2010, 383 (1/2) : 161-169.
  • 10Qiao M,Luo Y,Zhang L. Sustained release coating of tablets with Eudragit(R) RS/RL using a novel electrostatic dry powder coating process[J].International Journal of Pharmaceutics,2010,(1-2):37-43.

共引文献13

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部